27642330|t|Antibacterial Activity of Polyaniline Coated Silver Nanoparticles Synthesized from Piper Betle Leaves Extract
27642330|a|Plants or natural resources have been found to be a good alternative method for nanoparticles synthesis. In this study, polyaniline coated silver nanoparticles (AgNPs) synthesized from Piper betle leaves extract were investigated for their antibacterial activity. Silver nanoparticles were prepared from the reduction of silver nitrate and NaBH4 was used as reducing agent. Silver nanoparticles and extracts were mixed thoroughly and then coated by polyaniline. Prepared nanoparticles were characterized by Visual inspection, Ultraviolet-visible spectroscopy (UV), Fourier transform infrared Spectroscopy (FT-IR), Transmission Electron Microscopy (TEM) techniques. Antibacterial activities of the synthesized silver nanoparticles were tested against Staphylococcus aureus ATCC 25923, Salmonella typhi ATCC 14028, Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853. UV-Vis spectrum of reaction mixture showed strong absorption peak with centering at 400 nm. The FT-IR results imply that Ag-NPs were successfully synthesized and capped with bio-compounds present in P. betle. TEM image showed that Ag-NPs formed were well dispersed with a spherical structures and particle size ranging from 10 to 30 nm. The result revealed that Ag-Extract NPs showed 32.78±0.64 mm zone of inhibition against S. aureus, whereas norfloxacin (positive control) showed maximum 32.15±0.40 mm zone of inhibition for S. aureus. Again, maximum zone of inhibition 29.55±0.45 mm was found for S. typhi, 27.12±0.38 mm for E. coli and 21.95±0.45 mm for P. aeruginosa. The results obtained by this study can't be directly extrapolated to human; so further studies should be undertaken to established the strong antimicrobial activity of Ag-Extract NPs for drug development program.
27642330	0	13	Antibacterial	T103	UMLS:C0279516
27642330	26	37	Polyaniline	T103	UMLS:C0962453
27642330	45	51	Silver	T103	UMLS:C0037125
27642330	83	109	Piper Betle Leaves Extract	T103	UMLS:C3643364
27642330	110	116	Plants	T204	UMLS:C0032098
27642330	223	228	study	T062	UMLS:C2603343
27642330	230	241	polyaniline	T103	UMLS:C0962453
27642330	249	255	silver	T103	UMLS:C0037125
27642330	295	321	Piper betle leaves extract	T103	UMLS:C3643364
27642330	350	363	antibacterial	T103	UMLS:C0279516
27642330	374	380	Silver	T103	UMLS:C0037125
27642330	431	445	silver nitrate	T103	UMLS:C0037129
27642330	450	455	NaBH4	T103	UMLS:C0074728
27642330	468	482	reducing agent	T103	UMLS:C0376446
27642330	484	490	Silver	T103	UMLS:C0037125
27642330	509	517	extracts	T103	UMLS:C0032081
27642330	559	570	polyaniline	T103	UMLS:C0962453
27642330	636	668	Ultraviolet-visible spectroscopy	T058	UMLS:C0037812
27642330	670	672	UV	T058	UMLS:C0037812
27642330	675	714	Fourier transform infrared Spectroscopy	T062	UMLS:C0206055
27642330	716	721	FT-IR	T062	UMLS:C0206055
27642330	724	773	Transmission Electron Microscopy (TEM) techniques	T058	UMLS:C0678118
27642330	775	788	Antibacterial	T103	UMLS:C0279516
27642330	819	825	silver	T103	UMLS:C0037125
27642330	860	892	Staphylococcus aureus ATCC 25923	T007	UMLS:C0038172
27642330	894	921	Salmonella typhi ATCC 14028	T007	UMLS:C0036125
27642330	923	950	Escherichia coli ATCC 25922	T007	UMLS:C0014834
27642330	955	988	Pseudomonas aeruginosa ATCC 27853	T007	UMLS:C0033809
27642330	990	1005	UV-Vis spectrum	T058	UMLS:C0037812
27642330	1086	1091	FT-IR	T062	UMLS:C0206055
27642330	1092	1099	results	T033	UMLS:C0587081
27642330	1189	1197	P. betle	T103	UMLS:C3643364
27642330	1199	1202	TEM	T058	UMLS:C0678118
27642330	1245	1254	dispersed	T082	UMLS:C0332624
27642330	1262	1282	spherical structures	T082	UMLS:C0332501
27642330	1415	1424	S. aureus	T007	UMLS:C0038172
27642330	1434	1445	norfloxacin	T103	UMLS:C0028365
27642330	1517	1526	S. aureus	T007	UMLS:C0038172
27642330	1535	1547	maximum zone	T082	UMLS:C1710706
27642330	1590	1598	S. typhi	T007	UMLS:C0036125
27642330	1618	1625	E. coli	T007	UMLS:C0014834
27642330	1648	1661	P. aeruginosa	T007	UMLS:C0033809
27642330	1692	1697	study	T062	UMLS:C2603343
27642330	1732	1737	human	T204	UMLS:C0086418
27642330	1742	1757	further studies	T062	UMLS:C0008972
27642330	1805	1818	antimicrobial	T103	UMLS:C1136254
27642330	1850	1874	drug development program	T091	UMLS:C0872152